Nxera Pharma Co., Ltd. (SOLTF)
5.19
0.00 (0.00%)
USD |
OTCM |
Dec 09, 16:00
Nxera Pharma Total Assets (Quarterly): 976.25M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 97.98B |
| PeptiDream Inc. | 525.27M |
| Stemcell Holdings, Inc. | -- |
| Healios KK | 117.32M |
| AnGes, Inc. | 44.77M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 531.69M |
| Shareholders Equity (Quarterly) | 444.57M |
| Debt to Equity Ratio | 0.9617 |
| Current Ratio | 3.141 |
| Net Debt Paydown Yield | 0.49% |